UnitedHealth Group (UNH) PT Raised to $161 at Oppenheimer
Get Alerts UNH Hot Sheet
Rating Summary:
28 Buy, 5 Hold, 2 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating and bumped his price target on UnitedHealth Group (NYSE: UNH) to $161.00 (from $145.00) following solid Q2 results despite ACA challenges.
Wiederhorn commented, "UNH reported 2Q16 adjusted EPS of $1.96 (GAAP: $1.81, includes $0.15 amortization), vs. OPCO/Street of $1.91/$1.89. The results were highlighted by Optum growth, and overcame $200M in additional ACA losses and negative prior-period reserve development. Following the quarter, UNH tweaked up the bottom-end of its FY2016 cash EPS guidance to $7.80-7.95, vs a prior range of $7.75-7.95 so we are tweaking our FY2016 EPS estimate to $7.91 from $7.88. Since UNH is largely exiting the Exchanges in 2017, the tailwind continues to grow larger. As a result, we are raising our FY2017 EPS estimate to $9.03 from $8.92 and our price target to $161 from $145."
For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.
Shares of UnitedHealth Group closed at $142.59 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hennes & Mauritz AB (HMB:SS) (HNNMY) PT Raised to SEK190 at RBC Capital, 'showing some promising signs '
- HSBC Downgrades Munich Re (MUV2:GR) (MURGY) to Reduce, 'dividend yield remains relatively low'
- BofA Securities Upgrades Estee Lauder (EL) to Buy; 'Earnings have bottomed'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!